African Poverty Related Infection Oriented Research Initiative Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2008
NCT00474435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

emtricitabine (emtriva) (1 trial)

tenofovir (viread) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2